IFAH-Europe (International Federation for Animal Health Europe) is the federation representing manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It represents both corporate members and national animal health associations in Europe. >>More
Human Influenza A (H1N1) virus and swine influenza in pigs: IFAH statement and Q&A
The current outbreak of the human disease, first reported in Mexico, is caused by a reassorted influenza A virus, type H1N1, now known as the Influenza A (H1N1) virus. This virus is different from swine influenza viruses found in pigs, and it also contains genes from avian and human influenza viruses (http://www.cdc.gov/h1n1flu/qa.htm).
The current strain of this Influenza A (H1N1) virus is transmitted from person to person. There are no food-safety issues related to this Influenza A (H1N1) virus. It cannot be passed to humans through food, by eating properly cooked pork or pork products. In general, the influenza virus A is killed by temperatures of 160°F/70°C, by proper hygiene measures and by common disinfectants.
See the IFAH statement and Q&A
IFAH-Europe annual report 2008 : Find out more about the priorities and achievements of IFAH-Europe in our newly published annaual report, available for download
IABS/IFAH-Europe workshop: Viral Safety & Extraneous Agents Testing for Veterinary Vaccines
The purity of starting materials, in-process products, and completed product is a primary concern to ensure the safety of veterinary vaccines. The workshop will bring together experts from the biologics industry, academia, and government regulatory agencies on 24-27 October 2009, Annecy, France. More
Perspectives newsletter no. 11: April issue
View the quarterly newsletter of IFAH-Europe. More
EMEA/IFAH-Europe Infoday: Latest developments in scientific review, legislation and marketing authorisation procedures
London. Representatives of European and national regulators as well as the Animal Health Industry met on the 12th and 13th March for the 2009 Infoday with the central theme “Latest developments in scientific review, legislation and marketing authorisation procedures” focussing on the core areas where regulatory professionals want to be kept up to date. more information
